The expected revenue is up from the previously-issued guidance of $670 million in 2013 revenue. NuVasive anticipates $725 million in revenue for 2014.
The company will announce its complete financial results for the fourth quarter and the full year after the market closes on March 3.
More Articles on Devices:
44 Spine & Orthopedic Devices Receive FDA 510(k) Clearance in December
MicroPort Scientific’s Acquisition Creates MicroPort Orthopedics Division
Mazor Robotics Pens Deal with Hospital GPO to Provide Renaissance System Access
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
